RNAシーケンシング市場：第2版

シーケンシング市場は、医療に大きな変化をもたらす可能性を秘めた強力なツールを提供し続けています。過去10年間、製品の導入、新しい用途、そしてこれらの新しい分野への参入を急ぐエンドユーザーのラボという点で、爆発的な成長が起こりました。近年、RNAシーケンシングがそれに取って代わり、凌駕するようになったため、RNA発現解析のためのマイクロアレイの使用は大きく減少しています。

当レポートでは、RNAシーケンシング製品（ハードウェア、ハードウェアのサービス、ソフトウェア、シーケンシングステップそのものを含む消耗品）市場に焦点を当てて、動向、課題、戦略、企業、製品について考察し、市場シェアと収益成長率について推定を提供しています。

調査内容：

• RNAシーケンシング市場（2021年・2026年）
• RNAシーケンシング消耗品市場（2021年・2026年）
• RNAシーケンシング装置関連サービス市場（2021年・2026年）
• RNAシーケンシングソフトウェア市場（2021年・2026年）
• RNAシーケンシングベンダーシェア
• 上市製品
• ソフトウェア製品
• イノベーション
• クリニカルシーケンシングと上市製品

目次

第1章 エグゼクティブサマリー

第2章 市場動向

• イントロダクション
• 動向
• 臨床診断、臨床研究用途
• がん - 白血病/血液疾患、固形腫瘍
• 感染症
• 希少遺伝/遺伝性疾患
• COVID-19
• Illuminaの多様な製品群
• その他の企業のNGS製品と技術
• CDCのSPHERE Consortium
• 継続的な新製品の導入
• シングルセルRNAシーケンシング
• 主要な製品/技術
• ソフトウェア/バイオインフォマティクス
• 多くの分野でのパートナーシップ、買収、取引

第3章 市場分析

• 市場分析
• 市場シェア

第4章 企業プロファイル

• Illumina
• Thermo Fisher Scientific
• New England Biolabs
• 10X Genomics
• Agilent Technologies
• Takara Bio Inc.
• Oxford Nanopore Technologies
• NuGen (Tecan)
• Pacific Biosciences of California, Inc. (PacBio)
• Standard BioTools

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:

• improved sensitivity and dynamic range

• ability to study species without reference

• measurement of focal changes (such as single nucleotide variants, insertions and deletions)

• detection of different transcript isoforms, splice variants and chimeric gene fusions (including previously unidentified genes and/or transcripts)

This report, “The Market for RNA Sequencing, 2nd Edition ”, focuses on the market for RNA sequencing products - the hardware, service of the hardware, software, and consumables including for the sequencing step itself. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.

Information in this report includes:

• RNA Sequencing Market, 2021 and 2026

• RNA Sequencing Consumables Market, 2021 and 2026

• RNA Sequencing Equipment-Related Services Market, 2021 and 2026

• RNA Sequencing Software Market, 2021 and 2026

• RNA Sequencing Vendor Share

• Products on The Market

• Software Products

• Innovations

• Clinical Sequencing and Products on the Market

The competitive situation, deals, and litigation are covered in respective chapters. The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

Companies Profiled Include:

• Illumina
• Agilent
• 10X Genomics
• Oxford Nanopore
• Thermo
• Roche
• Qiagen
• and Others

Table of Contents

Chapter 1: Executive Summary

• Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (in millions of $)
• Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
• Scope and Methodology
• Report Structure

Chapter 2: Market Trends

• Introduction
• Trends
• Clinical Diagnostics, Clinical Research Applications
• Cancer - leukemia/ hematological diseases; solid tumors
• Infectious diseases
• Rare inherited/ genetic diseases
  • Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies
• COVID-19
• Illumina's Diverse Range of Products
• Other Companies' NGS Products and Technologies
• CDC's SPHERES Consortium
• Ongoing Introductions of New Products
  • Table 2-2: RNA-Sequencing Product Introductions, August 2017- August 2022
• Single-Cell RNA Sequencing
• Selected Products/ Technologies
  • Table 2-3: Selected RNA-Seq Products and Technologies
• Software/ Bioinformatics
  • Table 2-4: Selected RNA-Seq Software and Related IT Tools
• Partnerships, Acquisitions, Deals in Many Areas
  • Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals

Chapter 3: Market Analysis

• Market Analysis
  • Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
  • Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
  • Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (percent)
  • Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
• Market Shares
  • Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2021 (millions of dollars and percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
  • Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
  • Figure 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)

Chapter 4: Company Profiles

• Illumina
• Thermo Fisher Scientific
• New England Biolabs
• 10X Genomics
• Agilent Technologies
• Takara Bio Inc.
• Oxford Nanopore Technologies
• NuGen (Tecan)
• Pacific Biosciences of California, Inc. (PacBio)
• Standard BioTools